Identification of Key Genes and Pathways in Oxaliplatin-Induced Neuropathic Pain Through Bioinformatic Analysis

References

• Chahal SK, Sodhi RK, Madan J. Duloxetine hydrochloride loaded film forming dermal gel enriched with methylcobalamin and geranium oil attenuates paclitaxel-induced peripheral neuropathy in rats. IBRO Rep. 2020;9:85–95. doi:10.1016/j.ibror.2020.07.006
   PubMedGoogle Scholar
• Misset JL. Oxaliplatin in practice. Br J Cancer. 1998;77 Suppl 4(Suppl 4):4–7. doi:10.1038/bjc.1998.428
   PubMedGoogle Scholar
• Kang L, Tian Y, Xu S, et al. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol. 2021;268(9):3269–3282. doi:10.1007/s00415-020-09942-w
   PubMed Web of Science ®Google Scholar
• Hershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941–1967. doi:10.1200/JCO.2013.54.0914
   PubMed Web of Science ®Google Scholar
• Veluchamy A, Hébert HL, Meng W, et al. Systematic review and meta-analysis of genetic risk factors for neuropathic pain. Pain. 2018;159(5):825–848. doi:10.1097/j.pain.0000000000001164
   PubMed Web of Science ®Google Scholar
• Gadepalli A, Ummadisetty O, Akhilesh A, et al. Peripheral mu-opioid receptor activation by dermorphin [D-Arg2, Lys4] (1-4) amide alleviates behavioral and neurobiological aberrations in rat model of chemotherapy-induced neuropathic pain. Neurotherapeutics. 2023;21(1):e00302. doi:10.1016/j.neurot.2023.10.012
   PubMedGoogle Scholar
• Gadepalli A, Ummadisetty O, Akhilesh A, et al. Loperamide, a peripheral Mu-Opioid receptor agonist, attenuates chemotherapy-induced neuropathic pain in rats. Int Immunopharmacol. 2023;124(Pt B):110944. doi:10.1016/j.intimp.2023.110944
   PubMedGoogle Scholar
• Cavaletti G, Tredici G, Petruccioli MG, et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer. 2001;37(18):2457–2463. doi:10.1016/S0959-8049(01)00300-8
   PubMed Web of Science ®Google Scholar
• McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer. 2001;85(8):1219–1225. doi:10.1054/bjoc.2001.2024
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991–995. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830–1831. doi:10.1093/bioinformatics/btt285
   PubMed Web of Science ®Google Scholar
• Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808–15. doi:10.1093/nar/gks1094
   PubMed Web of Science ®Google Scholar
• Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431–432. doi:10.1093/bioinformatics/btq675
   PubMed Web of Science ®Google Scholar
• Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–W97. doi:10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Dittmer DP, Damania B. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update. Curr Opin Virol. 2013;3(3):238–244. doi:10.1016/j.coviro.2013.05.012
   PubMed Web of Science ®Google Scholar
• Aloisi F, Giovannoni G, Salvetti M. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol. 2023;22(4):338–349. doi:10.1016/S1474-4422(22)00471-9
   PubMed Web of Science ®Google Scholar
• Abdelkader NF, Ibrahim SM, Moustafa PE, et al. Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways. Biomed Pharmacother. 2022;145:112395.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Q, Han X, et al. Electroacupuncture Alleviates Diabetic Peripheral Neuropathy by Regulating Glycolipid-Related GLO/AGEs/RAGE Axis. Front Endocrinol. 2021;12:655591. doi:10.3389/fendo.2021.655591
   PubMed Web of Science ®Google Scholar
• Oshitari T. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina. Int J Mol Sci. 2023;24(3):2927. doi:10.3390/ijms24032927
   PubMed Web of Science ®Google Scholar
• Liang YH, Chen GW, Li XS, et al. Guanosine-5’-triphosphate cyclohydrolase 1 regulated long noncoding RNAs are potential targets for microglial activation in neuropathic pain. Neural Regen Res. 2021;16(3):596–600. doi:10.4103/1673-5374.290914
   PubMed Web of Science ®Google Scholar
• Kwon SY, Yeom JH, Joo JD. Ketamine reduces the induced spinal p38 MAPK and pro-inflammatory cytokines in a neuropathic rats. Korean J Anesthesiol. 2014;66(1):52–58. doi:10.4097/kjae.2014.66.1.52
   PubMedGoogle Scholar
• Rodriguez Parkitna J, Korostynski M, Kaminska-Chowaniec D, et al. Comparison of gene expression profiles in neuropathic and inflammatory pain. J Physiol Pharmacol. 2006;57(3):401–414.
   PubMed Web of Science ®Google Scholar
• Ferrari LF, Khomula EV, Araldi D, et al. CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia. J Neurosci. 2018;38(2):308–321. doi:10.1523/JNEUROSCI.2695-17.2017
   PubMed Web of Science ®Google Scholar
• Bonet IJM, Staurengo-Ferrari L, Araldi D, et al. Second messengers mediating high-molecular-weight hyaluronan-induced antihyperalgesia in rats with chemotherapy-induced peripheral neuropathy. Pain. 2022;163(9):1728–1739. doi:10.1097/j.pain.0000000000002558
   PubMed Web of Science ®Google Scholar
• Denes A, Thornton P, Rothwell NJ, et al. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun. 2010;24(5):708–723. doi:10.1016/j.bbi.2009.09.010
   PubMed Web of Science ®Google Scholar
• Wei J, Su W, Zhao Y, et al. Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury. J Neuroinflammation. 2022;19(1):32. doi:10.1186/s12974-022-02405-1
   PubMed Web of Science ®Google Scholar
• Pan Z, Shan Q, Gu P, et al. miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis. J Neuroinflammation. 2018;15(1):29. doi:10.1186/s12974-018-1073-0
   PubMed Web of Science ®Google Scholar
• Islam B, Stephenson J, Young B, et al. The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics. Neuromolecular Med. 2022;24(3):320–338. doi:10.1007/s12017-021-08694-8
   PubMed Web of Science ®Google Scholar
• Kuthati Y, Goutham Davuluri VN, Yang CP, et al. Melatonin MT2 receptor agonist IIK-7 produces antinociception by modulation of ROS and suppression of spinal microglial activation in neuropathic pain rats. J Pain Res. 2019;12:2473–2485. doi:10.2147/JPR.S214671
   PubMed Web of Science ®Google Scholar
• Madiai F, Goettl VM, Hussain SR, et al. Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain. J Mol Neurosci. 2005;27(3):315–324. doi:10.1385/JMN:27:3:315
   PubMed Web of Science ®Google Scholar